Subscribe
istock-669281432_nataliaderiabina
NataliaDeriabina / iStockphoto.com
2 January 2019Americas

Court invalidates Illumina patents in Ariosa row

Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Got a patent, now where to validate?
22 March 2021   For smaller companies and universities, deciding where to validate a pharma patent can be difficult. Sarah Kostiuk-Smith of Mewburn Ellis looks at the options within the European Patent Convention countries.
Biotechnology
BGI takes Illumina to court over patent infringement in US
29 May 2019   A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor.
Americas
Illumina and Sequenom take on Ariosa in DNA patent infringement case
17 May 2018   Illumina and Sequenom have filed a patent infringement case against Ariosa Diagnostics for a patent covering DNA testing in pregnant women.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
Got a patent, now where to validate?
22 March 2021   For smaller companies and universities, deciding where to validate a pharma patent can be difficult. Sarah Kostiuk-Smith of Mewburn Ellis looks at the options within the European Patent Convention countries.
Biotechnology
BGI takes Illumina to court over patent infringement in US
29 May 2019   A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor.
Americas
Illumina and Sequenom take on Ariosa in DNA patent infringement case
17 May 2018   Illumina and Sequenom have filed a patent infringement case against Ariosa Diagnostics for a patent covering DNA testing in pregnant women.

More on this story

Big Pharma
Got a patent, now where to validate?
22 March 2021   For smaller companies and universities, deciding where to validate a pharma patent can be difficult. Sarah Kostiuk-Smith of Mewburn Ellis looks at the options within the European Patent Convention countries.
Biotechnology
BGI takes Illumina to court over patent infringement in US
29 May 2019   A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor.
Americas
Illumina and Sequenom take on Ariosa in DNA patent infringement case
17 May 2018   Illumina and Sequenom have filed a patent infringement case against Ariosa Diagnostics for a patent covering DNA testing in pregnant women.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB